What do peptides do in the body?

They carry signals. Peptide hormones like insulin, GLP-1 and oxytocin bind specific receptors and trigger specific responses: glucose uptake, satiety, uterine contraction. What any individual peptide does depends entirely on its sequence and its receptor; there is no general 'peptide effect.' That specificity is exactly why they make good drugs and why generic peptide marketing is meaningless.

The question only makes sense per category. Approved peptide drugs have safety profiles in their labels. Collagen supplements are digested as food and trials report only minor GI complaints. Cosmetic peptides have good topical safety records. Research peptides from unregulated vendors are the unanswerable case: whatever the molecule's intrinsic profile, an unverified vial has no quality guarantee, which is why PepVise links to no vendor.

Are peptides steroids?

No. Steroids are small lipid molecules built on a cholesterol backbone; peptides are amino-acid chains. The confusion comes from gym culture, where both get discussed as 'enhancement.' Some research peptides (the growth-hormone secretagogues like ipamorelin and CJC-1295) aim at the growth-hormone axis, which is hormone-adjacent territory, but chemically and legally they are a different class entirely.

What is the difference between peptides and proteins?

Length. Both are amino-acid chains; the rough convention puts the boundary near 50 residues. Insulin at 51 sits right on the line. Functionally, proteins tend to fold into complex working structures (enzymes, antibodies) while peptides usually act as compact signals. Collagen the protein and collagen peptides illustrate it: same amino acids, but hydrolysis chops the structural protein into short absorbable signal fragments.

Do any over-the-counter peptides actually work?

Two categories have real human data. Oral collagen peptides improved skin hydration and elasticity across a 19-trial meta-analysis and helped activity-related joint pain in a 24-week RCT. Topical palmitoyl pentapeptide-4 and copper tripeptide-1 (GHK-Cu) have controlled facial studies behind them. Effects in both cases are modest and take 8 to 12 weeks. Everything else on the shelf is running on borrowed credibility.

Compound profile· Mechanism

What are peptides, actually

By The PepVise Editorial Team · Reviewed June 4, 2026 · 12 min read

Peptide drugs, research compounds, collagen powders and skincare serums all share one word and almost nothing else. The chemistry, the four categories, and an honest map of which claims have evidence.

We describe what has been measured — by whom, at what scale, with what effect size, and with what caveats. Hedging, here, is honesty.

— The PepVise Editorial Teamfrom the house style guide

Methodology

How we read the literature

Evidence tier: We grade the literature on four tiers, High (replicated RCTs or meta-analyses), Moderate (multiple trials with mixed findings), Low (a single pilot or case series), and Anecdotal (preclinical only, no human data). The tier appears on every compound profile beside the claim it supports.
Trial stage: Where a compound sits in the human development pipeline is recorded as Preclinical, Phase 1, Phase 2, or Phase 3+. We pull the current stage from ClinicalTrials.gov and the EU Clinical Trials Register on access date and re-verify quarterly.
Regulatory status: We state the FDA posture plainly, approved for indication X, or labeled for research use only, or removed from the 503A list, or investigational under a specific IND. Regulatory status changes; every post carries a review date.
Where we're uncertain: Every compound profile closes with a named uncertainty section, the question we can't answer from the current literature, the trial we'd want to see, the effect size we'd treat as a real signal. Uncertainty is not a failure mode here; it's load-bearing.

Frequently asked

The questions readers actually bring us.

What do peptides do in the body?: They carry signals. Peptide hormones like insulin, GLP-1 and oxytocin bind specific receptors and trigger specific responses: glucose uptake, satiety, uterine contraction. What any individual peptide does depends entirely on its sequence and its receptor; there is no general 'peptide effect.' That specificity is exactly why they make good drugs and why generic peptide marketing is meaningless.
Are peptides safe?: The question only makes sense per category. Approved peptide drugs have safety profiles in their labels. Collagen supplements are digested as food and trials report only minor GI complaints. Cosmetic peptides have good topical safety records. Research peptides from unregulated vendors are the unanswerable case: whatever the molecule's intrinsic profile, an unverified vial has no quality guarantee, which is why PepVise links to no vendor.
Are peptides steroids?: No. Steroids are small lipid molecules built on a cholesterol backbone; peptides are amino-acid chains. The confusion comes from gym culture, where both get discussed as 'enhancement.' Some research peptides (the growth-hormone secretagogues like ipamorelin and CJC-1295) aim at the growth-hormone axis, which is hormone-adjacent territory, but chemically and legally they are a different class entirely.
What is the difference between peptides and proteins?: Length. Both are amino-acid chains; the rough convention puts the boundary near 50 residues. Insulin at 51 sits right on the line. Functionally, proteins tend to fold into complex working structures (enzymes, antibodies) while peptides usually act as compact signals. Collagen the protein and collagen peptides illustrate it: same amino acids, but hydrolysis chops the structural protein into short absorbable signal fragments.
Do any over-the-counter peptides actually work?: Two categories have real human data. Oral collagen peptides improved skin hydration and elasticity across a 19-trial meta-analysis and helped activity-related joint pain in a 24-week RCT. Topical palmitoyl pentapeptide-4 and copper tripeptide-1 (GHK-Cu) have controlled facial studies behind them. Effects in both cases are modest and take 8 to 12 weeks. Everything else on the shelf is running on borrowed credibility.

What would change our reading

A Phase 2 randomized trial with blinded outcome assessment would change the reading. A new independent replication outside the currently dominant research group would change the reading. A regulatory action — approval, restriction, or a class warning — would change the reading. When any of those lands, we update this profile within a week and mark what changed.

The sources

References cited on this page.

PubMed, ClinicalTrials.gov, and FDA documents only. Secondary sources appear when needed to characterize public discourse, never as a source for a clinical claim.

The masthead

About The Pepvise Editorial Team

The Pepvise Editorial Team is a small group of researchers and science writers reading the peer-reviewed peptide literature and translating it into calm, cited analysis. We do not sell peptides, recommend peptides, or tell readers what to administer. We describe what has been measured, by whom, at what scale, with what effect size.

Compound reviews are signed off by Dr. Priya Narang, MD, MPH (endocrinologist) and Dr. Marcus Haley, PharmD, BCPS (board-certified clinical pharmacist). Both hold verifiable state-board licenses and have signed editorial-independence letters with us. See the full editorial board →

Adjacent in the literature.

Mechanism · Compound profile

How Peptides Signal, A Primer for Informed Readers

Amino acid chains, receptor binding, signaling cascades, a rigorous but accessible explainer of peptide pharmacology.

14 min read

Get the 2026 Peptide Evidence Ledger.

A 12-page PDF summary of where 10 major compounds sit, Preclinical / Human pilot / Phase trial / FDA status. Updated quarterly. Free.

By subscribing, you agree to our Privacy Policy. One calm, cited email a week. Unsubscribe anytime.